Information;Judgment — ECLI:EU:T:2019:819
Date: 2019-11-28
Language of the case: English
Court formation: Fifth Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded
Origin: Germany

Judgment of the General Court of 28 November 2019 — August Wolff v EUIPO Faes Farma (DermoFaes Atopimed) (Case T-642/18) 1 (EU trade mark — Opposition proceedings — Application for EU word mark DermoFaes Atopimed — Earlier EU word mark Dermowas — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001) Language of the case: English Parties Applicant: Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany) (represented by: A. Thünken, lawyer) Defendant: European Union Intellectual Property Office (represented by: J. Ivanauskas and H. O’Neill, Agents) Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Faes Farma, SA (Lamiaco-Leioa, Spain) (represented by: A. Vela Ballesteros and S. Fernandez Malvar, lawyers) Re: Action brought against the decision of the Second Board of Appeal of EUIPO of 11 July 2018 (Case R 1365/2017-2) relating to opposition proceedings between Dr. August Wolff and Faes Farma. Operative part of the judgment The Court: Dismisses the action; Orders Dr. August Wolff GmbH & Co. KG Arzneimittel to bear its own costs and to pay the costs incurred by the European Union Intellectual Property Office (EUIPO) and by Faes Farma, SA, including those necessarily incurred by Faes Farma, SA, before the Board of Appeal of EUIPO ____________ 1 OJ C 4, 7.1.2019.